These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 12700045

  • 1. A review of human papillomavirus vaccines: from basic science to clinical trials.
    Berry JM, Palefsky JM.
    Front Biosci; 2003 May 01; 8():s333-45. PubMed ID: 12700045
    [Abstract] [Full Text] [Related]

  • 2. Human papillomavirus vaccines.
    Stanley MA.
    Curr Opin Mol Ther; 2002 Feb 01; 4(1):15-22. PubMed ID: 11883690
    [Abstract] [Full Text] [Related]

  • 3. Progress in prophylactic and therapeutic vaccines for human papillomavirus infection.
    Stanley MA.
    Expert Rev Vaccines; 2003 Jun 01; 2(3):381-9. PubMed ID: 12903803
    [Abstract] [Full Text] [Related]

  • 4. Papillomavirus-like particle vaccines.
    Schiller JT, Lowy DR.
    J Natl Cancer Inst Monogr; 2001 Jun 01; (28):50-4. PubMed ID: 11158207
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Emerging human papillomavirus vaccines.
    Christensen ND.
    Expert Opin Emerg Drugs; 2005 Feb 01; 10(1):5-19. PubMed ID: 15757400
    [Abstract] [Full Text] [Related]

  • 7. [Anti-papillomavirus vaccines and prevention of cervical cancer: progress and prospects].
    Hantz S, Alain S, Denis F.
    Presse Med; 2005 Jun 04; 34(10):745-53. PubMed ID: 16026130
    [Abstract] [Full Text] [Related]

  • 8. Papillomavirus-like particles for serology and vaccine development.
    Kirnbauer R.
    Intervirology; 1996 Jun 04; 39(1-2):54-61. PubMed ID: 8957670
    [Abstract] [Full Text] [Related]

  • 9. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C, Roden RBS, Kirnbauer R.
    Virus Res; 2017 Mar 02; 231():166-175. PubMed ID: 27889616
    [Abstract] [Full Text] [Related]

  • 10. [Possibilities of vaccination against HPV infections in cervix carcinoma].
    Gissmann L.
    Zentralbl Gynakol; 2001 May 02; 123(5):299-301. PubMed ID: 11449623
    [Abstract] [Full Text] [Related]

  • 11. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M, Fochesato M, Miseur A, Mertens E, Dendouga N, Brendle S, Balogh KK, Christensen ND, Giannini SL.
    J Virol; 2016 Jul 15; 90(14):6314-25. PubMed ID: 27147749
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus vaccines.
    Breitburd F, Coursaget P.
    Semin Cancer Biol; 1999 Dec 15; 9(6):431-44. PubMed ID: 10712890
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
    Tomson TT, Roden RB, Wu TC.
    Curr Opin Investig Drugs; 2004 Dec 15; 5(12):1247-61. PubMed ID: 15648945
    [Abstract] [Full Text] [Related]

  • 14. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
    Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco E.
    Int J Cancer; 2003 Oct 10; 106(6):896-904. PubMed ID: 12918067
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Papillomavirus vaccines.
    Duggan-Keen MF, Brown MD, Stacey SN, Stern PL.
    Front Biosci; 1998 Dec 01; 3():D1192-208. PubMed ID: 9835649
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.